Apolipoprotein E Sendai (arginine 145 → proline): A new variant associated with lipoprotein glomerulopathy

Journal of the American Society of Nephrology

Volumn 8, Issue 5, 1997, Pages 820-823

  Oikawa, Shinichi ^a   Matsunaga, Akira ^b   Saito, Takao ^a   Sato, Hiroshi ^a   Seki, Takafumi ^a   Hoshi, Katsuhiko ^a   Hayasaka, Kyoko ^a   Kotake, Hidetoshi ^a   Midorikawa, Hiroshi ^a   Sekikawa, Akihiro ^a   Hara, Susumu ^a   Abe, Keishi ^a   Toyota, Takayoshi ^a   Jingami, Hisato ^c   Nakamura, Haruki ^c   Sasaki, Jun ^b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c BIOMOL ENG RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ARTICLE; CASE REPORT; DNA SEQUENCE; GLOMERULOPATHY; HUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0030783855     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v85820     Document Type: Article

References (22)

1. Saito T, Sato H, Kudo K, Oikawa S, Shibata T, Hara Y, Yoshinaga K, Sakaguchi H: Lipoprotein glomerulopathy: Glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia. Am J Kidney Dis 13: 148-153, 1989
2. Watanabe Y, Ozaki I, Yoshida F, Fukatsu A, Itoh Y, Matsuo S, Sakamoto N: A case of nephrotic syndrome with glomerular lipoprotein deposition with capillary ballooning and mesangiolysis. Nephron 51: 265-270, 1989
3. Koitabashi Y, Ikoma M, Miyahara T, Fujita R, Mio H, Ishida M, Shimizu K, Sakaguchi H: Long-term follow-up of a paediatric case of lipoprotein glomerulopathy. Pediatr Nephrol 4: 122-128, 1990
4. Churg J, Bernstein J, Glassock RJ: Lipoprotein glomerulopathy. In: Renal Disease: Classification and Atlas of Glomerular Disease, 2nd Ed., edited by Churg J, Bernstein J, Glassock RJ, New York, Igaku-Shoin, 1995, pp 450-451
5. Glassock RJ, Cohen AH, Adler SG: Primary glomerular disease. In: Brenner and Rector's The Kidney, 5th Ed., edited by Brenner BM, Philadelphia, W.B. Saunders, 1996, pp 1392-1497
6. Saito T, Sato H, Oikawa S: Lipoprotein glomerulopathy: A new aspect of lipid induced glomerular injury. Nephrology 1: 17-24, 1995
7. Komatsu T, Kanatsu K, Ochi H, Kita T, Doi T: Lipoprotein glomerulopathy with a new apolipoprotein E phenotype. Am J Kidney Dis 26: 952-953, 1995
8. Oikawa S, Suzuki N, Sakuma E, Saito T, Namai K, Kotake H, Fujii Y, Toyota T: Abnormal lipoprotein and apolipoprotein pattern in lipoprotein glomerulopathy. Am J Kidney Dis 18: 553-558, 1991
9. Moriyama K, Sasaki J, Matsunaga A, Arakawa F, Takada Y, Araki K, Kaneko S, Arakawa K: Apolipoprotein E1 Lys 146→Glu with type III hyperlipoproteinemia. Biochem Biophys Acta 1005: 239-244, 1992
10. Takada Y, Sasaki J, Seki M, Ogata S, Teranishi Y, Arakawa K: Characterization of a new human apolipoprotein A-I Yame by direct sequencing of polymerase chain reaction-amplified DNA. J Lipid Res 32: 1275-1280, 1991
11. Emi M, Wu LL, Robertson A, Myers RL, Hegele RA, Williams RR, White R, Lanlouel TM: Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3: 373-379, 1988
12. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548, 1990
13. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622-630, 1988
14. Weisgraber KH: Apolipoprotein E: Structure-function relationships. Adv Protein Chem 45: 249-302, 1994
15. de Knijff P, van den Maagdenberg AM, Frants RR, Havekes LM: Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum Mutat 4: 178-194, 1994
16. Lalazar A, Weisgraber KH, Rail SC, Jr, Giladi H, Innerarity TL, Levanon AZ, Boyles JK, Amit B, Gorecki M, Mahley RW, Vogel T: Site-specific mutagenesis of human apolipoprotein E: Receptor binding activity of variants with single amino acid substitutions. J Biol Chem 263: 3542-3545, 1988
17. Rail SC Jr, Newhouse YM, Clarke HR, Weisgraber K, McCarthy BJ, Mahley RW, Bersot TP: Type III hyperlipoproteinemia associated with apolipoprotein phenotype E3/3: Structure and genetics of an apolipoprotein E3 variant. J Clin Invest 83: 1095-1101, 1989
18. Rail SC, Jr, Weisgraber KH, Innerarity TL, Mahley RW: Structural basis for receptor binding heterogeneioty of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA 79: 4696-700, 1982
19. Lohse P, Rader DJ, Brewer B Jr: Heterozygosity for apolipoprotein E-4 Philadelphia (Glu13→Lys, Arg145→Cys) is associated with incomplete dominance of type III hyperlipoproteinemia. J Biol Chem 267: 13642-13646, 1992
20. Rail SC Jr, Weisgraber KH, Innerarity TL, Bersot TP, Mahley RW, Blum CB: Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J Clin Invest 72: 1288-1297, 1983
21. Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U: Apolipoprotein E-3 Leiden: A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet 73: 157-163, 1986
22. Barlow DJ, Thornton JM: Helix geometry in proteins. J Mol Biol 201: 601-619, 1988